The density of CXCL12+ stromal cells is significantly elevated in the bone marrow of patients with MDS and AML with myelodysplasia-related changes (AML-MRC), compared to controls (no morphologic abnormalities in bone marrow) and AML. Here, CXCL12 is linked to acute myeloid leukemia.